VKTX SCHEDULE 13G/A: SEC filing

An institutional filer

Filed with the SEC on Nov 5, 2026 · accession 0000315066-26-002856

VKTX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 5, 2026. An institutional filer submitted an amended Schedule 13G for Viking Therapeutics (VKTX), indicating a change in their passive ownership position.

Summary of the filing

An institutional filer submitted an amended Schedule 13G for Viking Therapeutics (VKTX), indicating a change in their passive ownership position. The filing directory does not disclose specific ownership percentages or share counts.

For details, click here →

Key details

Subject companyViking Therapeutics, Inc.

✦ Ask GOAX AI about this filing — what it means for VKTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VKTX?

Click here

Frequently asked questions

What did VKTX file with the SEC on Nov 5, 2026?

VKTX filed a SCHEDULE 13G/A (SEC filing). An institutional filer submitted an amended Schedule 13G for Viking Therapeutics (VKTX), indicating a change in their passive ownership position. The filing directory does not disclose specific ownership percentages or share counts.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other VKTX SEC filings

Get alerts when VKTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

VKTX overview VKTX analysis VKTX news Latest SEC filings